Abstract: A power provision device including: a load element; a power supply plane configured to provide current to the load element; a plurality of power supply elements configured to provide current to the power supply plane; wherein each power supply element is configured to provide a current corresponding to a plurality of selectable current values to the power supply plane via an individual power connection; and wherein each of the plurality of power supply elements comprises a controller configured to control the power supply element to: transmit information to and receive information from other power supply elements of the plurality of power supply elements; select a current value based on information received from other power supply elements, wherein the information includes a current supplied by the other power supply elements; and output a current corresponding to the selected current value.

Abstract: A method for operating a voltage regulator circuit for converting an input voltage into an output voltage comprising an input port for receiving an input voltage, an output port for providing an output voltage, an output voltage reference circuit configured to output a reference voltage, an overshoot detection device, an inductive device, and an overshoot reduction control circuit comprising a peak comparator device, the method comprising: in response to detecting, by the overshoot detection device, that the output voltage exceeds a first threshold, generating a first control signal configured to turn on an overshoot reduction function configured to reduce the output voltage; determining when to end the overshoot reduction function by: detecting, using the peak comparator device if the output voltage crosses a second threshold and; if the output voltage is detected to have crossed the second threshold, generating a second control signal configured to control the overshoot protection function to end.

Abstract: A regulator circuit for use with circuitry is provided. The circuitry includes a switching converter. The switching converter includes, at least, a high-side switching device and a low-side switching device coupled in series between an input node at an input voltage and a reference node. The circuitry further includes a bootstrap capacitor coupled to the high-side switching device for supplying a drive voltage for operating the high-side switching device. The regulator circuit is configured to regulate charging of the bootstrap capacitor during a time period when the high-side switching device is turned on, so as to compensate for a voltage drop across the bootstrap capacitor resulting from the high-side switching device being turned on.

Abstract: A controller for a multi-phase switching converter including multiple phase circuits is provided. The multi-phase switching converter is configured to receive an input voltage, generate an output voltage, and provide a load current. The controller includes a current threshold generator configured to generate a first threshold current that is dependent on the input voltage and/or the output voltage, a comparator system configured to compare the load current to the first threshold current, and a phase control system configured to change the number of active phase circuits based on the comparison between the load current and the first threshold current.

Abstract: The invention relates to a novel process for obtaining direct sulfation of unprotected sugars, in particular polysaccharides, using ecologically acceptable solvents.

Abstract: The invention relates to a novel process for obtaining direct sulfation of unprotected sugars, in particular polysaccharides, using ecologically acceptable solvents.

Abstract: A multi-deck circuit arrangement including a first deck circuit having a negative supply terminal and a second deck having a positive supply terminal connected to the negative supply terminal. A single power supply provides a voltage across both the first and second decks. The total power consumption will be less than the prior art of having both deck circuits conventionally regulated. The supply rail connecting the second deck's positive supply terminal to the first deck's negative supply terminal may be regulated. In one embodiment, the rail voltage can be controlled to optimize deck circuit operation for speed and power and to avoid level shifters when interfacing to other circuits.

Abstract: A multi-deck circuit arrangement including a first deck circuit having a negative supply terminal and a second deck having a positive supply terminal connected to the negative supply terminal. A single power supply provides a voltage across both the first and second decks. The total power consumption will be less than the prior art of having both deck circuits conventionally regulated. The supply rail connecting the second deck's positive supply terminal to the first deck's negative supply terminal may be regulated. In one embodiment, the rail voltage can be controlled to optimize deck circuit operation for speed and power and to avoid level shifters when interfacing to other circuits.

Abstract: Improvements in or relating to transparent units (such as glazing units, which may also be referred to as insulating glass units) and their methods of manufacture are disclosed. Each transparent unit comprises first and second panes of transparent material each having an outwardly facing side and an inwardly facing side. Each inwardly facing side is at least partially coated with a reactive interlayer made by the application of a reactive interlayer coating composition. The inwardly facing side of the first and second panes of transparent material are spaced apart partially or totally by a transparent spacer made of a pre-cured condensation curable material or a substantially pre-cured condensation curable material adhered to the inwardly facing side of the first and second panes of transparent material by way of the reactive interlayers. In various embodiments, the pre-cured condensation curable material is a silicone based material.

Abstract: The invention relates to the salt of (SS)-adenosyl methionine with myo-inositol 1,2,3,4,5,6 hexakisphosphate, and pharmaceutical, nutraceutical or veterinary formulations containing it.

Abstract: Disclosed is a low molecular weight (1000-5000 daltons) chondroitin sulfate (CS) produced by chemical sulfation of a non-sulfated chondroitin backbone (K4 capsular polysaccharide) obtained with biotechnology techniques. The CS described is substantially monosulfated, mainly at the 6-position, with very little sulfation at the 4-position, and with a mono/disulfated disaccharide ratio and charge density similar to those of natural CS. Said biotechnological chondroitin sulfate (CS) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes.

Abstract: Improvements in or relating to transparent units (such as glazing units, which may also be referred to as insulating glass units) and their methods of manufacture are disclosed. Each transparent unit comprises first and second panes of transparent material each having an outwardly facing side and an inwardly facing side. Each inwardly facing side is at least partially coated with a reactive interlayer made by the application of a reactive interlayer coating composition. The inwardly facing side of the first and second panes of transparent material are spaced apart partially or totally by a transparent spacer made of a pre-cured condensation curable material or a substantially pre-cured condensation curable material adhered to the inwardly facing side of the first and second panes of transparent material by way of the reactive interlayers. In various embodiments, the pre-cured condensation curable material is a silicone based material.

Abstract: Disclosed are solid forms of menaquinol and processes for obtaining them by chemical or enzymatic reduction of menaquinone. Said solid forms possess high stability to oxidation which allows effective use of menaquinol in the most common formulations wherein vitamin K2 is used.

Abstract: Disclosed is a low molecular weight (1000-5000 daltons) chondroitin sulfate (CS) produced by chemical sulfation of a non-sulfated chondroitin backbone (K4 capsular polysaccharide) obtained with biotechnology techniques. The CS described is substantially monosulfated, mainly at the 6-position, with very little sulfation at the 4-position, and with a mono/disulfated disaccharide ratio and charge density similar to those of natural CS. Said biotechnological chondroitin sulfate (CS) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes.

Abstract: The invention relates to the salt of (SS)-adenosyl methionine with myo-inositol 1,2,3,4,5,6 hexakisphosphate, and pharmaceutical, nutraceutical or veterinary formulations containing it.

Abstract: Disclosed are solid forms of menaquinol and processes for obtaining them by chemical or enzymatic reduction of menaquinone. Said solid forms possess high stability to oxidation which allows effective use of menaquinol in the most common formulations wherein vitamin K2 is used.

Abstract: The present invention discloses a process for the production of chondroitin sulphate with an average molecular weight (Mw) of 10-30 kDa by chemical sulphation starting from an unsulphated chondroitin backbone, obtained in turn by acid hydrolysis of capsular polysaccharide K4 made directly from E. coli strain O5:K4:H4, or directly produced from a genetically modified strain of E. coli. Sulphation of the N-acetyl-D-galactosamine residue at position 4 or 6 takes place simultaneously in the same polysaccharide chain, simulating the sulphation pattern observed in natural chondroitin sulphate, unlike the sulphation obtained with the synthesis methods described to date.

Abstract: Disclosed are two novel crystalline forms of S-acetyl glutathione (SAG) called Form A and Form B, obtained by crystallization of SAG from mixtures of water-acetone, water-ethanol or water acetone under controlled conditions. Forms A and B can be advantageously used as ingredients of pharmaceutical or nutraceutical formulations.

Abstract: A process for the preparation of a chondroitin sulphate salt with an average molecular weight (Mw) of 10-30 kDa via chemical sulphation of an unsulphated chondroitin backbone is provided. The unsulphated chondroitin can be obtained by acid hydrolysis of a capsular polysaccharide K4 made directly from E. coli strain O5:K4:H4 or directly produced from a genetically modified strain of E. coli. Sulphation of the N-acetyl-D-galactosamine residue at position 4 or 6 takes place simultaneously in the same polysaccharide chain, simulating the sulphation pattern observed in natural chondroitin sulphate.

Abstract: Disclosed are two novel crystalline forms of S-acetyl glutathione (SAG) called Form A and Form B, obtained by crystallisation of SAG from mixtures of water-acetone, water-ethanol or water acetone under controlled conditions. Forms A and B can be advantageously used as ingredients of pharmaceutical or nutraceutical formulations.